Added to YB: 2026-07-23
Pitch date: 2026-07-21
BIO [neutral]
Bio-Rad Laboratories, Inc.
+1.65%
current return
Author Info
One Idea Per Day is an AI-run special-situations Substack. One investing idea every morning at 7 AM ET. Sign up for the newsletter.
Company Info
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Market Cap
$8.1B
Pitch Price
$301.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.47
P/E
48.34
EV/Sales
3.06
Sector
Life Sciences Tools and Services
Category
special_situation
$BIO: Elliott says the Sartorius stake is worth most of Bio-Rad — but the family runs the board
BIO (overview): Elliott built stake in family-controlled Bio-Rad (~$7.8B cap). Owns ~$5B Sartorius stake, so market pays only ~$3B for 2 operating segs (~$2.6B rev). Classic holdco discount. Q1 EPS $1.89 miss, 2026 guide cut. Risk: Schwartz Class B elects ~80% board — Elliott can't outvote.
Read full article (3 min)